TGFB1 and neoplasm: TGFβ1 is a highly immunosuppressive cytokine that contributes to tumor immune escape by inhibiting antitumor T-cell activity [21], thereby reducing the efficiency and efficacy of immunotherapies that involve the activation of T cells.